Jiang Shaohai, Hong Y Alicia
Department of Communications and New Media, National University of Singapore, Singapore.
Both authors contribute equally.
Digit Health. 2021 Dec 14;7:20552076211067658. doi: 10.1177/20552076211067658. eCollection 2021 Jan-Dec.
Public participation in a clinical trial is the foundation of clinical research and the cornerstone for the discovery of new treatment and improving health outcomes. This study aims to examine how eHealth engagement, patient-provider communication, and clinical trial knowledge are associated with clinical trial participation in the United States.
Data were drawn from the Health Information National Trends Survey Iteration 5 Cycle 4 conducted in 2020. The sample included 3865 American adults aged 18 years and above. Path analysis using structural equation modeling and hierarchical linear regression was performed to examine the effects of eHealth engagement and patient-provider communication on clinical trial participation.
About 5% of American adults have ever participated in a clinical trial. Younger adults, males, minorities, and people with lower education, less clinical trial knowledge, and less eHealth engagement were less likely to participate. After controlling for demographic variables, we found that more eHealth engagement led to a better knowledge of clinical trials, which was strongly associated with participation. Further, patient-centered communication did not directly lead to clinical trial participation; instead, it positively moderated the relationship between clinical trial knowledge and participation.
The national survey data indicate that American participation in clinical trials remains low and a significant disparity exists. Within the context of the eHealth movement, it is critical to implement targeted interventions to improve clinical trial knowledge, address the digital divide, and enhance patient-centered communication.
公众参与临床试验是临床研究的基础,也是发现新疗法和改善健康结果的基石。本研究旨在探讨在美国,电子健康参与度、医患沟通以及临床试验知识与临床试验参与之间的关联。
数据取自2020年进行的《健康信息国家趋势调查》第5轮第4周期。样本包括3865名18岁及以上的美国成年人。采用结构方程模型和分层线性回归进行路径分析,以检验电子健康参与度和医患沟通对临床试验参与的影响。
约5%的美国成年人曾参与过临床试验。年轻人、男性、少数族裔以及教育程度较低、临床试验知识较少且电子健康参与度较低的人参与的可能性较小。在控制人口统计学变量后,我们发现更多的电子健康参与会带来对临床试验更好的了解,而这与参与密切相关。此外,以患者为中心的沟通并不会直接导致参与临床试验;相反,它正向调节了临床试验知识与参与之间的关系。
全国性调查数据表明,美国参与临床试验的比例仍然较低,且存在显著差异。在电子健康运动的背景下,实施有针对性的干预措施以提高临床试验知识、解决数字鸿沟并加强以患者为中心的沟通至关重要。